UP Pharma Conclave Highlights State's Competitive Edge in Pharmaceutical Sector
In a significant development for the pharmaceutical industry, Uttar Pradesh has positioned itself as a leading destination for investments through competitive policies and incentives. Industrial development, export promotion, and investment minister Nand Gopal Gupta 'Nandi' made this announcement while addressing the UP Pharma Conclave held in Lucknow on Tuesday.
Comprehensive Support for Pharma Investments
Minister Nandi emphasized that Uttar Pradesh offers some of the most attractive policies and incentives in the country for pharmaceutical investments. He highlighted that this advantage is further strengthened by improved law and order conditions and robust investor facilitation mechanisms that have been implemented across the state.
The minister pointed out that Uttar Pradesh has witnessed remarkable industrial and economic growth in recent years, creating an exceptionally favorable environment for pharmaceutical and healthcare manufacturing sectors to thrive. He described medicines and pharmaceuticals as powerful symbols of hope and trust in society, while acknowledging doctors as lifesavers who play a crucial role in healthcare delivery.
Focus on Inclusive Industrial Development
During his address, Nandi stressed the importance of inclusive and well-planned industrial development that is supported by effective on-ground implementation. He called for strategic approaches that would benefit all stakeholders in the pharmaceutical ecosystem while maintaining high standards of quality and accessibility.
The conclave featured two important sessions that attracted active participation from industry experts and stakeholders. The first session focused on 'Competitive Pharma Ecosystem – Infrastructure, Industry and Regulation', while the second explored 'Pharma, Medical Devices and GCC Sector: Research and Innovation'.
Government Officials Highlight State's Strengths
Minister of state for health and family welfare Mayankeshwar Sharan Singh reinforced the state's commitment to the pharmaceutical sector, describing Uttar Pradesh as a catalyst for change that actively supports innovation, manufacturing, and investment. He emphasized the state's progressive approach to creating an enabling environment for pharmaceutical companies.
Nandi further elaborated on sector-specific initiatives undertaken by the state government, including Uttar Pradesh's proactive response during the challenging Covid-19 pandemic period. He highlighted several key aspects of the state's pharmaceutical strategy:
- The crucial role of drug inspectors in maintaining quality standards
- Foreign Direct Investment (FDI)-friendly policies designed to attract global players
- Comprehensive investor hand-holding systems to facilitate business establishment
- Focused development initiatives for the Bundelkhand region
- The strategic importance of the Lalitpur bulk drug park project
Infrastructure and Development Advantages
The CEO of Yamuna Expressway Industrial Development Authority (YEIDA) highlighted the availability of industrial land in the region, positioning it as a preferred destination for pharmaceutical investments. This infrastructure advantage complements the state's policy initiatives to create a comprehensive ecosystem for pharmaceutical companies.
Minister of food safety, drug administration, and Ayush, Daya Shankar Mishra 'Dayalu', also participated in the conclave, underscoring the government's multi-departmental approach to supporting the pharmaceutical sector.
Comprehensive Presentation of State's Capabilities
Additional chief secretary (Industrial Development and MSME) Alok Kumar presented 'Destination Uttar Pradesh', a comprehensive overview of the state's strengths and advantages for pharmaceutical investors. The presentation highlighted several key factors:
- Strong Micro, Small and Medium Enterprises (MSME) ecosystem
- One District One Product (ODOP) initiatives supporting local manufacturing
- Reliable power availability across industrial zones
- Substantial land bank for industrial development
- Excellent connectivity through road, rail, and air networks
- Consistent Gross State Domestic Product (GSDP) growth indicating economic vitality
Vast Market Potential Recognized
Concluding the deliberations, Chief Minister's advisor GN Singh highlighted the state's vast pharmaceutical market potential, emphasizing Uttar Pradesh's position as one of India's largest markets for pharmaceutical products. This market size, combined with the state's strategic initiatives, creates compelling opportunities for both domestic and international pharmaceutical companies looking to expand their presence in India.
The UP Pharma Conclave served as a platform to showcase the state's comprehensive approach to pharmaceutical sector development, combining policy incentives, infrastructure development, and strategic initiatives to create an attractive investment destination within India's growing pharmaceutical landscape.
